Is Palantir Stock Overvalued?
By every traditional yardstick, including a price‑to‑sales well above 100,…
Buy
54
TRVI Quote, Financials, Valuation and Earnings
Last price:
$6.09
Seasonality move
:
-6.99%
Day range:
$6.05 - $6.34
52-week range:
$2.36 - $7.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.23x
Volume:
1.1M
Avg. volume:
1.9M
1-year change:
119.86%
Market cap:
$619.6M
Revenue:
--
EPS (TTM):
-$0.45
Earnings Data
Next earnings date for TRVI
Aug 08
2025
Most recent earnings per share
-$0.09
Beat by $0.03
(May 8/2025)
Consensus Estimate
-$0.12
(May 8/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TRVI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/08/2025 | Q2 | -- | -- | -- | -$0.10 | -- |
| 05/08/2025 | Q1 | -- | -- | -$0.09 | -$0.12 | $0.03 |
| 03/18/2025 | Q4 | -- | -- | -$0.11 | -$0.12 | $0.01 |
| 11/06/2024 | Q3 | -- | -- | -$0.13 | -$0.11 | -$0.02 |
| 08/08/2024 | Q2 | -- | -- | -$0.12 | -$0.11 | -$0.01 |
| 05/07/2024 | Q1 | -- | -- | -$0.11 | -$0.09 | -$0.02 |
| 03/20/2024 | Q4 | -- | -- | -$0.08 | -$0.09 | $0.01 |
| 11/09/2023 | Q3 | -- | -- | -$0.08 | -$0.09 | $0.01 |
| 08/10/2023 | Q2 | -- | -- | -$0.07 | -$0.09 | $0.02 |
| 05/11/2023 | Q1 | -- | -- | -$0.06 | -$0.07 | $0.01 |
| 03/16/2023 | Q4 | -- | -- | -$0.06 | -$0.10 | $0.04 |
| 11/10/2022 | Q3 | -- | -- | -$0.12 | -$0.13 | $0.01 |
| 08/11/2022 | Q2 | -- | -- | -$0.14 | -$0.19 | $0.05 |
| 05/12/2022 | Q1 | -- | -- | -$0.24 | -$0.29 | $0.05 |
| 03/17/2022 | Q4 | -- | -- | -$0.24 | -$0.30 | $0.06 |
| 11/10/2021 | Q3 | -- | -- | -$0.34 | -$0.40 | $0.06 |
| 08/12/2021 | Q2 | -- | -- | -$0.49 | -$0.46 | -$0.03 |
| 05/13/2021 | Q1 | -- | -- | -$0.43 | -$0.52 | $0.09 |
| 03/25/2021 | Q4 | -- | -- | -$0.51 | -$0.44 | -$0.07 |
| 11/11/2020 | Q3 | -- | -- | -$0.41 | -$0.51 | $0.10 |
| 08/12/2020 | Q2 | -- | -- | -$0.41 | -$0.48 | $0.07 |
| 05/07/2020 | Q1 | -- | -- | -$0.48 | -$0.44 | -$0.04 |
| 03/16/2020 | Q4 | -- | -- | -$0.37 | -$0.51 | $0.15 |
| 11/14/2019 | Q3 | -- | -- | -$0.41 | -$0.48 | $0.07 |
| 08/12/2019 | Q2 | -- | -- | -$0.41 | -$0.42 | $0.01 |
| 06/13/2019 | Q1 | -- | -- | -- | -$0.52 | -- |
Trevi Therapeutics Earnings Questions
-
How Much did Trevi Therapeutics Generate in Revenue Last Quarter?
Trevi Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Trevi Therapeutics Beat Earnings Last Quarter?
Trevi Therapeutics announced earnings per share of -$0.09 which represents a beat of analyst forecast a -$0.12 per share.
-
Is Trevi Therapeutics Profitable?
Trevi Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Trevi Therapeutics EPS Next Year?
Trevi Therapeutics's earnings are forecast to decrease from -$0.47 per share to -$0.43 per share next year representing a decrease of -6.74%.
-
When is Trevi Therapeutics's Earnings Date?
Trevi Therapeutics's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Gamestop’s Bitcoin Strategy Going To Succeed?
When GameStop (NYSE: GME) announced in Q1 that its board had…
How High Will Roku Stock Go?
Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 48x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Sell
11
VEON alert for Jun 14
VEON [VEON] is down 18.57% over the past day.
Buy
74
DAVE alert for Jun 14
Dave [DAVE] is down 12.68% over the past day.
Buy
54
DAR alert for Jun 14
Darling Ingredients [DAR] is up 9.12% over the past day.
